3. Gandini L., Lombardo F., Culasso F., Dondero F., Lenzi A. Myth and reality of the decline in semen quality: an example of the relativity of data interpretation. J Endocrinol Invest 2000; 23: 402–11.
4. Swan S.H., Elkin E.P., Fenster L. The question of declining sperm density revisited, an analysis of 101 studies published 1934–1996. Environ Health Perspect 2000; 108: 961–6.
5. WHO manual for the standardized investigation, diagnosis and management of the infertile male. Rowe P., Comhaire F., Hargreave B., Mahmoud A., eds. Cambridge: Cambridge University Press: 2000: 37–60.
6. Nieschlag E. Care for the infertile male. Clin Endocrinol 1993; 38: 123–33.
7. O’Donovan P.A., Vandekerckhove P., Lilford R.J., Hughes E. Treatment of male infertility: Is it effective? Review and Meta-analyses of published randomized controlled trials. Hum Reprod 1993; 8: 1209–22.
8. Kamischke A., Nieschlag E. Analysis of medical treatment of male infertility. Hum Reprod 1999; 14(Suppl 1): 1–23.
9. Adamopoulos D.A. Present and future therapeutic strategies for idiopathic oligozoospermia. Int J Androl 2000; 23: 320–31.
10. Oehninger S. Clinical and laboratory management of male infertility: an opinion on its current status. J Androl 2000; 21: 814–21.
11. Scottish Infertility Group. The effect of clomiphene citrate and vitamin C for male infertility: a randomized trial. Brit J Urol 1982; 54: 780–4.
12. Scottish Infertility Group. The effect of mesterolone versus vitamin C for male infertility: a randomized trial. Brit J Urol 1984; 56: 740–4.
13. Knuth U.A., Honingl W., Bals-Pratsch M., Schleicher G., Nieschlag E. Treatment of severe oligozoospermia with hCG/hMG, a placebo-controlled, double blind trial. J Clin Endoc Metab 1987; 65: 1081–7.
14. World Health Organization. Mesterolone and idiopathic male infertility, a double blind study. Int J Androl 1989; 12: 254–9.
15. World Health Organization. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl 1992; 15: 299–307.
16. Lenzi A., Culasso F., Gandini L., Lombardo F., Dondero F. Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 1993; 8: 1657–62.
17. Keck C., Behre H.M., Jockenho¨vel F., Nieschlag E. Ineffectiveness of kallikrein in treatment of idiopathic male infertility: a double-blind, randomized, placebo-controlled trial. Hum Reprod 1994; 9: 325–9.
18. Kessopoulou E., Powers H.J., Sharma K.K., Pearson M.J., Russell J.M., Cooke I.D. et al. A double blind randomized placebo controlled trial using the antioxidant vitamin E to treat oxygen species associated male infertility. Fertil Steril 1995; 64: 825–31.
19. Vandekerckhove P., Lilford R., Hughes E. The medical treatment of idiopathic oligo/asthenospermia, androgens (mesterolone or testosterone) versus placebo or no treatment. In: Lilford R., Hughes E., Vandekerckhove P., eds. Subfertility module of the Cochrane database of systematic reviews. Oxford: The Cochrane Library, Update Software, 1996.
20. Vandekerckhove P., Lilford R., Hughes E. The medical treatment of oligo/asthenospermia, anti-oestrogens (clomiphene or tamoxifen) versus placebo or no treatment. In: Lilford R., Hughes E., Vandekerckhove P., eds. Subfertility module of the Cochrane database of systematic reviews. Oxford: The Cochrane Library, Update Software, 1998.
21. Kamischke A., Behre H.M., Bergmann M., Simoni M., Schafer T., Nieschlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 1998; 13: 596–603.
22. Rolf C., Cooper T.G., Yeung C.H., Nieschlag E. Antioxidant treatment of patients with asthenozoospermia a moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebocontrolled, double blind study. Hum Reprod 1999; 14: 1028–33.
23. Lenzi A., Picardo M., Gandini L., Lombardo F., Terminali O., Passi S. et al. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod 1994; 9: 2044–50.
24. Lenzi A., Picardo M., Gandini L., Dondero F. Lipids of sperm plasma membrane: from polyunsaturated fatty acid considered as markers of sperm function to possible scavenger therapy. Hum Reprod Update 1996; 2: 246–56.
25. Lenzi A., Gandini L., Picardo M. A rationale for glutatione therapy. In debate on: is antioxidant therapy a promising strategy to improve human reproduction? Hum Reprod 1998; 13: 1419–22.
26. Frenkel R.A., Mc Garry J.D., eds. Carnitine biosyntesis, metabolism and function. [Italian edition] New York: Academic Press, 1984.
27. Peluso G., Nicolai R., Reda E., Benatti P., Barbarisi A., Calvani M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 2000; 182: 339–50.
28. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J 1992; 123: 1726–7.
29. Costa M., Canale D., Filicori M., D’Iddio S., Lenzi A. L-carnitine in idiopathic asthenozoospermia, a multicenter study. Andrologia 1994; 26: 155–9.
30. Vicari E., Calogero A.E. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod 2001; 16: 2338–42.
31. World Health Organization. Laboratory manual for the examination of human semen and semen-cervical mucus interaction, 4th ed. Cambridge: Cambridge University Press, 1999.
32. Soufir J.C., Marson J., Jouannet P. Free L-carnitine in human seminal plasma. Int J Androl 1981; 4: 388–97.
33. Aitken R.J., Clarkson J.S., Fishel S. Generation of reactive oxygen species, lipid peroxidation and human sperm function. Biol Reprod 1989; 41: 183–97.
34. Gandini L., Menditto A., Chiodo F., Lenzi A. Italian pilot study for an external quality control scheme in semen analysis and antisperm antibiotics detection. Int J Androl 2000; 23: 1–3.
35. Lenzi A. Computer-aided semen analysis (CASA) 10 years later, a test-bed for the European scientific andrological community. Int J Androl 1997; 20: 1–2.
36. Dondero F., Gandini L., Lombardo F., Salacone P., Caponecchia L., Lenzi A. Antisperm antibody detection: 1. Methods and standard protocol. Am J Reprod Immunol 1997; 38: 218–23.
37. Bolton S. Pharmaceutical statistics practical and clinical application. New York: Marcell Dekker, 1997: 410–5.
38. Nieschlag E., Leifke E. Empirical therapies for male idiopathic infertility. In: Nieschlag E., Behre G., eds. Andrology: male reproductive health and dysfunction. Berlin: Springer Verlag, 1997: 313–24.
39. Ruiz-Pesini E., Alvarez E., Enriquez J.A., Lopez-Perez M.J. Association between seminal plasma carnitine and mitochondrial enzymatic activities. Int J Androl 2001; 24: 335–40.
40. Comhaire F. Clinical andrology: from evidence-base to ethics. The «E» quintet in clinical andrology. Hum Reprod 2000; 15: 2067–71.
41. Radford J.A. Is prevention of sterility possible in men? Ann Oncol 2000; 11(Suppl 3): 173–4.
42. Sandlow J.I. Shattering the myths about male infertility. Treatment of male factors may be more successful and cost-effective than you think. Postgrad Med 2000; 107: 235–9.
43. Falcone T. What the internist needs to know about infertility. Cleve Clin J Med 2001; 68: 65–72.